Finance

Lists
ELAN:NYSE
Elanco Animal Health Inc
$ 22.55
+0.51%
(+0.11) 1D
$ 22.55
0.00% (0.00)
After hours
Closed: 10-р сарын 14, 16:00:05 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELAN...
Open
$ 22.38
High
$ 22.92
Low
$ 22.26
Mkt. cap
11.27 тэрбум
Avg. vol.
5.31 сая
Volume
4.94 сая
52-wk high
$ 27.98
52-wk low
$ 19.40
EPS
-$ 0.42
Beta
1.71
Shares outstanding
499.62 сая
No. of employees
10 мян
Open
$ 22.38
High
$ 22.92
Low
$ 22.26
Mkt. cap
11.27 тэрбум
Avg. vol.
5.31 сая
Volume
4.94 сая
52-wk high
$ 27.98
52-wk low
$ 19.40
EPS
-$ 0.42
Beta
1.71
Shares outstanding
499.62 сая
No. of employees
10 мян
News stories
From web sources and news partners
Profile
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
About Elanco Animal Health Inc
CEOJeffrey N. Simmons
Employees9.65 мян
Founded1954
HeadquartersИндианаполис, Индиана, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websiteelanco.com
Analyst ratings
Based on 12 analysts giving stock ratings to ELAN in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ELAN in the last 3 months.
Highest
Current $ 22.55
$ 34.00 (+50.78%)
Average
$ 31.44 (+39.42%)
Lowest
$ 26.00 (+15.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Clark
Leerink Partners
Buy
Reiterated
$ 34.00
+50.8%
10/01/2026
Jonathan Block
Stifel Nicolaus
Buy
Reiterated
-
-
09/18/2026
Steve Scala
TD Cowen
Buy
Reiterated
$ 32.00
+41.9%
08/25/2026
Glen Santangelo
Barclays
Buy
Maintained
$ 30.00
+33%
08/21/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
$ 34.00
+50.8%
08/12/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/12/2026
Chris Schott
J.P. Morgan
Buy
Maintained
-
-
08/11/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
$ 26.00
+15.3%
08/10/2026
David Westenberg
Piper Sandler
Buy
Maintained
$ 30.00
+33%
08/10/2026
Andrea Alfonso
UBS
Buy
Maintained
$ 33.00
+46.3%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
$ 34.00
+50.8%
08/06/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
$ 30.00
+33%
08/06/2026
Jasper Hellweg
Argus Research
Buy
Maintained
-
-
06/23/2026
Umer Raffat
Evercore ISI
Buy
Maintained
-
-
05/11/2026
Unknown Analyst
Jefferies
Buy
Maintained
$ 30.00
+33%
02/25/2026
Last report
2026 оны 8-р сарын 5
Fiscal period
Q2 2026
$ 0.34 / $ 0.27
+26.46%beat
Revenue / Est. (USD)
1.37 тэрбум / 1.31 тэрбум
+4.16%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.14 тэрбум
1.14 тэрбум
1.37 тэрбум
1.37 тэрбум
Cost of goods sold
530.00 сая
555.00 сая
586.00 сая
570.00 сая
Cost of revenue
530.00 сая
555.00 сая
586.00 сая
570.00 сая
Research and development expenses
89.00 сая
93.00 сая
97.00 сая
92.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
351.00 сая
331.00 сая
381.00 сая
449.00 сая
Operating expense
580.00 сая
563.00 сая
616.00 сая
680.00 сая
Total operating expenses
1.11 тэрбум
1.12 тэрбум
1.20 тэрбум
1.25 тэрбум
Operating income
27.00 сая
26.00 сая
169.00 сая
118.00 сая
Other non operating income
2.00 сая
-15.00 сая
-8.00 сая
-11.00 сая
EBT including unusual items
-50.00 сая
-259.00 сая
87.00 сая
56.00 сая
EBT excluding unusual items
-25.00 сая
-37.00 сая
103.00 сая
65.00 сая
Income tax expense
-16.00 сая
17.00 сая
30.00 сая
2.00 сая
Effective tax rate
32.00%
-6.56%
34.48%
3.57%
Other operating expenses
-
-
-
-
Net income
-34.00 сая
-276.00 сая
57.00 сая
54.00 сая
Net profit margin
-2.99%
-24.13%
4.16%
3.95%
Earnings per share
0.19
0.13
0.40
0.34
Interest and investment income
-
45.00 сая
-
-
Interest expense
-52.00 сая
-105.00 сая
-57.00 сая
-59.00 сая
Net interest expenses
-52.00 сая
-60.00 сая
-57.00 сая
-59.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
195.00 сая
194.00 сая
335.00 сая
283.00 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс